The news comes after the company’s flagship Galaxy System, a lung nodule diagnostic tool, received FDA clearance.
The company will use the funding round to meet rising demand for the Galaxy System, according to an April 19 Noah Medical news release.
Softbank Vision Fund led the financing round.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
